Homepage > Company > Media > Blog > 2021 > CHEMDIV IN PUBLICATIONS AND PATENTS

CHEMDIV IN PUBLICATIONS AND PATENTS

We are passionate about the latest trends in life sciences and medicinal chemistry and closely monitoring the latest developments and discoveries in this area.

It means a lot to us if our customers find hits among compounds that they purchased from ChemDiv. All articles and patents that resulted from screening ChemDiv's small molecule chemistry have been collected on this page.

Worldwide scientists make the world a better place with the help of ChemDiv's services.

Check the latest publications on virtual screening and small-molecule drug discovery ⬇

https://store.chemdiv.com/about/publications/

Read also

CHEMDIV IS NOW A DISCOVERY PARTNER WITH GWYNANT THERAPEUTICS AND CELYN THERAPEUTICS

ChemDiv has been selected as a discovery partner with Gwynant Therapeutics and Celyn Therapeutics and starts to work on novel small molecules for oncology targets.

Our covalent compound library is now available in a ready-to-dock format for BioSolveIT

ChemDiv,Inc.

Science & Nature reviews, August 2021 (2)

These are ChemDiv's reviews on Nature and Science Journal articles.

OCULAR DISEASES SMALL MOLECULES LIBRARY

ChemDiv presets a brand new OCULAR DISEASES SMALL MOLECULES LIBRARY (13,000 compounds, 7 targets, 4 diseases)For design of screening library we use emerging Targets.